Fermenta Biotech Ltd Press Release Dec 02 2025
Filed with BSE · · 1 page · English
Ref: F.No.: 908 December 2, 2025 Sir, Ref: Code No.: 506414 Subject: Intimation of investor meeting. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. Kindly note that changes may happen due to exigencies on the part of the Company/investor. VARADVINAYAK VIJAY KHAMBETE Varadvinayak Khambete Company Secretary & Head – Legal Membership No. A33861
Earlier from Fermenta Biotech
- Fermenta Biotech Ltd Press Release Nov 12 2025
- Fermenta Biotech Ltd Press Release Nov 11 2025
- Fermenta Biotech Ltd Press Release Oct 29 2025
- Fermenta Biotech Ltd Press Release Oct 24 2025
- Fermenta Biotech Ltd Press Release Sep 30 2025
Later from Fermenta Biotech
- Fermenta Biotech Ltd Press Release Dec 07 2025
- Fermenta Board Approves INR 110 Crore Capex at Dahej for Plant-based Vitamin D3, Green Chemistry Enzyme, and Vitamin D3 Derivatives
- Fermenta Biotech Ltd Press Release Dec 24 2025
- Fermenta Ranked Among India's Best Workplaces™ in Pharmaceuticals, Healthcare & Biotech by Great Place to Work®
- Fermenta Biotech Ltd Press Release Dec 29 2025
Follow Fermenta Biotech into a list and get an email when it puts out news.
Follow Fermenta Biotech